---
title: "Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292674163.md"
description: "Regeneron Pharmaceuticals (REGN) shares fell 1.05% to $656.12, marking its third consecutive day of losses and closing 20.09% below its 52-week high. Despite the decline, REGN outperformed peers like Amgen and Gilead Sciences on a day when major indices rose modestly. Trading volume remained significantly below the 50-day average."
datetime: "2026-07-14T20:44:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292674163.md)
  - [en](https://longbridge.com/en/news/292674163.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292674163.md)
---

# Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) slid 1.05% to $656.12 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,543.59 and the Dow Jones Industrial Average rising 0.02% to 52,508.27.

This was the stock's third consecutive day of losses.

Regeneron Pharmaceuticals Inc. closed 20.09% below its 52-week high of $821.11, which the company reached on January 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Amgen Inc. (AMGN) fell 1.44% to $355.25, Moderna Inc. (MRNA) rose 0.64% to $67.44, and Gilead Sciences Inc. (GILD) fell 1.04% to $130.04.

Trading volume (472,152) remained 587,391 below its 50-day average volume of 1.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 14, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-14-26 1644ET

### Related Stocks

- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)

## Related News & Research

- [If You Invested $1000 In Regeneron Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/295958013.md)
- [12:50 ETREGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt](https://longbridge.com/en/news/295826897.md)
- [USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/296020218.md)
- [15:34 ETRegeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman](https://longbridge.com/en/news/295967459.md)
- [NewEdge Advisors LLC Has $5.88 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/295508474.md)